Published in Invest Ophthalmol Vis Sci on March 01, 2004
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2010) 3.49
Evolving guidelines for intravitreous injections. Retina (2004) 3.39
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology (2005) 3.20
A comparison of same setting versus delayed vitrectomy in the management of retained lens fragments after cataract surgery. Retina (2014) 2.00
Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina (2012) 1.95
Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology (2006) 1.80
Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema. Br J Ophthalmol (2012) 1.71
Choroidal neovascularization after epiretinal membrane removal. Arch Ophthalmol (2006) 1.70
The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology (2002) 1.70
Lamina puncture for central retinal vein occlusion: results of a pilot trial. Arch Ophthalmol (2006) 1.39
Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. Ophthalmology (2005) 1.34
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol (2006) 1.32
Acute posterior multifocal placoid pigment epitheliopathy: outcome and visual prognosis. Retina (2009) 1.19
Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol (2005) 1.17
Retinal microvascular surgery: a feasibility study. Invest Ophthalmol Vis Sci (2004) 1.17
Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol (2002) 1.17
Pseudophakic cystoid macular edema. Semin Ophthalmol (2003) 1.16
Cataract surgery as a risk factor for retinal detachment in very highly myopic eyes. Ophthalmology (2003) 1.13
Clinicopathologic reports, case reports, and small case series: surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma. Arch Ophthalmol (2003) 1.10
Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology (2003) 1.01
Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina (2006) 1.00
Lamina puncture: pars plana optic disc surgery for central retinal vein occlusion. Arch Ophthalmol (2002) 1.00
Optical coherence tomography predicts visual outcome in macula-involving rhegmatogenous retinal detachment. Clin Ophthalmol (2012) 0.96
Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy. Mediators Inflamm (2013) 0.89
Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis. Retina (2002) 0.89
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography. Clin Ophthalmol (2010) 0.88
Surface epithelialization of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Ultra-widefield imaging for the management of pediatric retinal diseases. J Pediatr Ophthalmol Strabismus (2013) 0.86
Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography. Clin Ophthalmol (2012) 0.86
Persistent suppression of ocular neovascularization with intravitreal administration of AAVrh.10 coding for bevacizumab. Hum Gene Ther (2011) 0.86
Subconjunctival bleb that forms at the injection site after intravitreal injection is drug, not vitreous. Clin Experiment Ophthalmol (2013) 0.84
Isolated foveal hypoplasia without nystagmus. Int Ophthalmol (2014) 0.83
Perfluorocarbon liquid utilization in primary vitrectomy repair of retinal detachment with multiple breaks. Retina (2003) 0.83
Vitreoretinal surgery in the setting of permanent keratoprosthesis. Arch Ophthalmol (2012) 0.83
Surgical and other treatments of diabetic macular edema: an update. Int Ophthalmol Clin (2004) 0.82
Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2004) 0.82
Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice. Ophthalmol Clin North Am (2006) 0.81
Trans-orbital foreign body with intracranial extension. J Trauma (2006) 0.81
Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin (2004) 0.81
Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function. PLoS One (2013) 0.79
Topical mecamylamine for diabetic macular edema. Am J Ophthalmol (2010) 0.79
Three-dimensional reconstruction and analysis of vitreomacular traction: quantification of cyst volume and vitreoretinal interface area. Arch Ophthalmol (2011) 0.78
Controversies in proliferative vitreoretinopathy tamponade and pharmacologic adjuvants. Int Ophthalmol Clin (2005) 0.78
Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration. Surv Ophthalmol (2007) 0.77
Controversies in intravitreal triamcinolone acetonide use. Int Ophthalmol Clin (2005) 0.76
Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema. Clin Ophthalmol (2012) 0.76
Elevated erythropoietin and vascular endothelial growth factor levels in an adolescent with retinal neovascularization from a chronic rhegmatogenous retinal detachment. Retin Cases Brief Rep (2008) 0.76
Dystrophic calcification of the fibrous capsule around a hydrogel explant 13 years after scleral buckling surgery: capsular calcification of a hydrogel explant. Retina (2005) 0.76
Volumetric three-dimensional reconstruction and segmentation of spectral-domain OCT. Ophthalmic Surg Lasers Imaging (2011) 0.75
Reply: To PMID 24853687. Retina (2014) 0.75
Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumab. J Ophthalmic Inflamm Infect (2011) 0.75
Cytomegalovirus retinitis after central retinal vein occlusion in a patient on systemic immunosuppression: does venooclusive disease predispose to cytomegalovirus retinitis in patients already at risk? Clin Ophthalmol (2012) 0.75
New methods for retinal examination in eyes with a Boston keratoprosthesis. Retina (2013) 0.75
Ultra-widefield fluorescein angiography of white without pressure. Clin Ophthalmol (2013) 0.75
Retinal necrosis secondary to inadvertent intravitreal methylprednisolone acetate (depo-medrol) injection during pars plana vitrectomy. Retin Cases Brief Rep (2009) 0.75
Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential. J Comput Assist Tomogr (2017) 0.75
CT characteristics of intraocular perfluoro-N-octane. AJNR Am J Neuroradiol (2003) 0.75
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2002- a 58-year-old woman with unilateral loss of vision and postmenopausal bleeding. N Engl J Med (2002) 0.75
Differences in Retinal Surgery Innovation Between the United States and European Union: Why We Do Things Differently. Int Ophthalmol Clin (2017) 0.75
In vivo redirection of retinal blood flow into borosilicate micro-cannulas in rabbits. Graefes Arch Clin Exp Ophthalmol (2006) 0.75
Contact lens intraocular foreign body presenting 1 year after traumatic open globe repair. Retin Cases Brief Rep (2009) 0.75
Resolution of leukemic retinopathy following treatment with imatinib mesylate for chronic myelogenous leukemia. Am J Ophthalmol (2003) 0.75